Word

GLPG

Status

Pending

Status Code

688

Status Date

Tuesday, November 28, 2023

Serial Number

98094108

Mark Type

4000

Filing Date

Thursday, July 20, 2023

Published for Opposition

Tuesday, October 3, 2023

Trademark Owner History

Galapagos NV - Owner At Publication

Classifications

5 pharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma; biopharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma

44 medical services; medical and pharmaceutical advisory and consultancy services; gene bank services

42 medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, chimeric antigen receptor T-cell therapy, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate those databases via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; gene bank services for research purposes

Trademark Events

Nov 28, 2023

Noa E-Mailed - Sou Required From Applicant

Nov 6, 2023

Assigned To Examiner

Oct 3, 2023

Official Gazette Publication Confirmation E-Mailed

Oct 3, 2023

Published For Opposition

Sep 13, 2023

Notification Of Notice Of Publication E-Mailed

Aug 26, 2023

Approved For Pub - Principal Register

Aug 21, 2023

Assigned To Examiner

Aug 20, 2023

New Application Office Supplied Data Entered

Jul 24, 2023

New Application Entered